PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 20124483-6 2010 Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion. 3,3"-diinodolylmethane 63-85 microRNA 146a Homo sapiens 123-131 20124483-6 2010 Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion. 3,3"-diinodolylmethane 63-85 epidermal growth factor receptor Homo sapiens 171-175 20124483-6 2010 Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion. 3,3"-diinodolylmethane 63-85 metastasis associated 1 family member 2 Homo sapiens 177-182 20124483-6 2010 Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion. 3,3"-diinodolylmethane 63-85 interleukin 1 receptor associated kinase 1 Homo sapiens 184-190 20124483-6 2010 Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion. 3,3"-diinodolylmethane 63-85 nuclear factor kappa B subunit 1 Homo sapiens 196-205 20124483-6 2010 Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion. 1,4-dideoxy-1,4-iminomannitol 87-90 microRNA 146a Homo sapiens 123-131 20124483-6 2010 Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion. 1,4-dideoxy-1,4-iminomannitol 87-90 epidermal growth factor receptor Homo sapiens 171-175 20124483-6 2010 Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion. 1,4-dideoxy-1,4-iminomannitol 87-90 metastasis associated 1 family member 2 Homo sapiens 177-182 20124483-6 2010 Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion. 1,4-dideoxy-1,4-iminomannitol 87-90 interleukin 1 receptor associated kinase 1 Homo sapiens 184-190 20124483-6 2010 Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion. 1,4-dideoxy-1,4-iminomannitol 87-90 nuclear factor kappa B subunit 1 Homo sapiens 196-205 20124483-6 2010 Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion. Isoflavones 95-105 microRNA 146a Homo sapiens 123-131 20124483-6 2010 Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion. Isoflavones 95-105 epidermal growth factor receptor Homo sapiens 171-175 20124483-6 2010 Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion. Isoflavones 95-105 metastasis associated 1 family member 2 Homo sapiens 177-182 20124483-6 2010 Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion. Isoflavones 95-105 interleukin 1 receptor associated kinase 1 Homo sapiens 184-190 20124483-6 2010 Treatment of pancreatic cancer cells with the natural products 3,3"-diinodolylmethane (DIM) or isoflavone, which increased miR-146a expression, caused a downregulation of EGFR, MTA-2, IRAK-1, and NF-kappaB, resulting in an inhibition of pancreatic cancer cell invasion. Isoflavones 95-105 nuclear factor kappa B subunit 1 Homo sapiens 196-205